查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1971789

自动化次世代定序样品製备市场分析及预测（至2035年）：依类型、产品类型、服务、技术、组件、应用、最终使用者、流程、部署类型及功能划分

Automated NGS Library Preparation Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Process, Deployment, Functionality
出版日期: | 出版商: Global Insight Services | 英文 371 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计自动化次世代定序样品製备市场将从2024年的6.778亿美元成长到2034年的22.981亿美元，复合年增长率约为13%。自动化NGS样品製备市场涵盖了能够提高次世代定序文库製备效率和准确性的系统和解决方案。这些自动化平台透过减少人工干预、最大限度地减少错误并提高通量，满足了人们对快速可靠基因组分析日益增长的需求。定序技术的进步、研究活动的增加以及对个人化医疗的需求是推动市场成长的主要因素，这些因素正在促进自动化和与生物资讯工具整合方面的创新。

受基因组研究进展和精准医疗需求成长的推动，自动化NGS样品製备市场持续稳定扩张。耗材板块增速最快，其中试剂和试剂盒是样品製备流程的关键组成部分。其次是自动化平台，整合系统因其能够提高通量并减少人为错误而备受关注。在耗材板块中，试剂子板块表现特别出色，反映出样品製备中对高品质起始材料的持续需求。同时，软体和资讯学板块增速位居第二，印证了资料管理和分析在NGS工作流程中的重要性。云端软体解决方案因其扩充性和易于研究人员存取而日益受到青睐，而本地部署解决方案则继续满足那些对资料管理有严格要求的机构的需求。个人化医疗的趋势以及对高效、高通量定序解决方案的需求是推动市场成长的关键因素，为创新和投资提供了丰厚的机会。

市场区隔
类型 全自动、半自动
产品 设备、试剂、耗材及配件
服务 维护与支援、咨询、安装、培训
科技 以微珠为基础的微流体
成分 软体、硬体
目的 诊断、药物发现、农业和动物研究
最终用户 医院和诊所、製药和生物技术公司、学术和研究机构
过程 样品製备、文库建构、定序与数据分析
实施表格 本机部署、云端部署
功能 高通量、低通量

市场概况：

自动化次世代定序样品製备市场呈现动态的市场格局，市场占有率不断变化。定价策略竞争激烈，反映了创新和新产品推出的快速步伐。这一趋势是由对高效、精准的基因测序解决方案日益增长的需求所驱动的。市场领导者正利用技术进步来丰富产品系列，并拓展多元化的基本客群。对自动化和精准度的关注正在重塑整个产业，各公司都在大力投资研发以保持竞争优势。自动化NGS样品製备市场的竞争异常激烈，主要参与者正透过创新和策略联盟来实现差异化。监管的影响，尤其是在北美和欧洲等地区，对市场动态的形成至关重要。这些法规确保了品质和安全，并影响产品开发和打入市场策略。与行业标准进行对标对于企业提升市场地位至关重要。市场分析表明，技术整合和遵守严格的法规结构是实现永续成长和竞争优势的关键。

主要趋势和驱动因素：

由于技术进步和对高通量定序需求的不断增长，自动化NGS样品製备市场正经历强劲成长。一个关键趋势是样品製备过程的自动化，这提高了效率并减少了人为错误。这种自动化是由科学研究和临床诊断领域对快速、高精度定序结果的需求所驱动的。另一个主要驱动因素是遗传疾病和癌症的日益普遍，这使得先进的定序技术对于早期检测和个人化医疗至关重要。政府和私人企业对基因组研究的投入不断增加也影响市场。这些投资正在推动创新并扩大NGS技术的应用范围。此外，人工智慧（AI）和机器学习在定序工作流程中的应用正在改善数据分析和解读。在NGS技术应用尚处于起步阶段的新兴市场，存在着许多机会。提供经济高效且扩充性解决方案的公司将占据有利地位，充分利用这一不断增长的市场潜力。

限制与挑战：

自动化NGS样品製备市场面临许多限制与挑战。首先，高昂的初始投资和营运成本阻碍了小规模实验室的采用。设备的复杂性需要专门的培训，这增加了营运成本，并限制了其快速整合到现有工作流程中。此外，监管环境不断变化，推出了严格的指导方针，这可能导致产品核可和市场准入的延迟。这给企业带来了不确定性，并有可能减缓创新步伐。另外，NGS技术产生的大量数据需要先进的生物资讯学工具和专业知识，这为数据管理和分析带来了挑战。平台间缺乏标准化，使系统互通性复杂化，并阻碍了无缝整合。最后，人们日益关注敏感基因资讯外洩问题，这进一步阻碍了市场扩张，引发了资料隐私和安全的担忧。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 全自动
    • 半自动
  • 市场规模及预测：依产品划分
    • 装置
    • 试剂和耗材
    • 配件
  • 市场规模及预测：依服务划分
    • 维护和支援
    • 咨询
    • 安装
    • 训练
  • 市场规模及预测：依技术划分
    • 以微珠为基础
    • 微流体技术
  • 市场规模及预测：依组件划分
    • 软体
    • 硬体
  • 市场规模及预测：依应用领域划分
    • 诊断
    • 药物发现
    • 农业和畜牧业调查
  • 市场规模及预测：依最终用户划分
    • 医院和诊所
    • 製药和生物技术公司
    • 学术研究机构
  • 市场规模及预测：依製程划分
    • 样品製备
    • 图书馆建设
    • 定序
    • 数据分析
  • 市场规模及预测：依发展状况
    • 本地部署
    • 基于云端的
  • 市场规模及预测：依功能划分
    • 高通量
    • 低吞吐量

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • PerkinElmer
  • Illumina
  • Qiagen
  • Takara Bio
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Tecan Group
  • Hamilton Company
  • Beckman Coulter Life Sciences
  • Analytik Jena
  • Eppendorf
  • Zymo Research
  • Promega Corporation
  • New England Biolabs
  • Nimagen

第九章：关于我们

简介目录
Product Code: GIS33647

Automated NGS Library Preparation Market is anticipated to expand from $677.8 million in 2024 to $2,298.1 million by 2034, growing at a CAGR of approximately 13%. The Automated NGS Library Preparation Market encompasses systems and solutions that streamline the preparation of next-generation sequencing libraries, enhancing efficiency and accuracy. These automated platforms reduce manual intervention, minimize errors, and increase throughput, catering to the growing demand for rapid and reliable genomic analysis. The market is driven by advancements in sequencing technologies, rising research activities, and the need for personalized medicine, fostering innovations in automation and integration with bioinformatics tools.

The Automated NGS Library Preparation Market is experiencing robust expansion, driven by advancements in genomic research and increasing demand for precision medicine. The consumables segment is the top-performing, as reagents and kits are indispensable for library preparation processes. Automation platforms follow closely, with integrated systems gaining prominence due to their ability to enhance throughput and reduce manual errors. Within consumables, the reagents sub-segment is particularly strong, reflecting the ongoing need for high-quality inputs in library preparation. Meanwhile, the software and informatics segment emerges as the second-highest performer, underscoring the importance of data management and analysis in NGS workflows. Cloud-based software solutions are gaining traction, providing scalability and ease of access for researchers, while on-premise solutions continue to serve organizations with stringent data control requirements. The trend towards personalized medicine and the need for efficient, high-throughput sequencing solutions are key drivers propelling market growth, offering lucrative opportunities for innovation and investment.

Market Segmentation
TypeFully Automated, Semi-Automated
ProductInstruments, Reagents and Consumables, Accessories
ServicesMaintenance and Support, Consultation, Installation, Training
TechnologyBead-Based, Microfluidics
ComponentSoftware, Hardware
ApplicationDiagnostics, Drug Discovery, Agricultural and Animal Research
End UserHospitals and Clinics, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes
ProcessSample Preparation, Library Construction, Sequencing, Data Analysis
DeploymentOn-Premise, Cloud-Based
FunctionalityHigh-Throughput, Low-Throughput

Market Snapshot:

The Automated NGS Library Preparation Market is characterized by a dynamic landscape where market share is continually evolving. Pricing strategies are competitive, reflecting the rapid pace of innovation and the introduction of new product launches. These developments are driven by the increasing demand for efficient and accurate genomic sequencing solutions. Market leaders are leveraging technological advancements to enhance their product portfolios, thereby attracting a diverse customer base. The focus on automation and precision is reshaping the industry, with companies investing heavily in research and development to maintain a competitive edge. Competition within the Automated NGS Library Preparation Market is intense, with key players striving for differentiation through innovation and strategic partnerships. Regulatory influences, particularly in regions like North America and Europe, are pivotal in shaping market dynamics. These regulations ensure quality and safety, impacting product development and market entry strategies. Benchmarking against industry standards is crucial for companies to enhance their market positioning. The market analysis reveals that technological integration and compliance with stringent regulatory frameworks are essential for sustained growth and competitive advantage.

Geographical Overview:

The Automated NGS Library Preparation Market is witnessing robust growth across diverse regions, each presenting unique opportunities. North America remains at the forefront, buoyed by advanced healthcare infrastructure and substantial investments in genomic research. The presence of key market players further propels growth in this region. Europe is not far behind, with strong governmental support for precision medicine and genomics driving market expansion. The region's commitment to innovation in healthcare technology fosters a conducive environment for market growth. In the Asia Pacific, rapid advancements in biotechnology and increasing healthcare expenditure are key growth drivers. Countries like China and India are emerging as significant players, owing to their large population base and growing focus on personalized medicine. Latin America and the Middle East & Africa are nascent markets with untapped potential. In Latin America, increasing research activities and collaborations are paving the way for market development, while the Middle East & Africa are gradually recognizing the importance of genomics in healthcare.

Key Trends and Drivers:

The Automated NGS Library Preparation Market is experiencing robust growth due to technological advancements and increasing demand for high-throughput sequencing. A significant trend is the automation of library preparation processes, which enhances efficiency and reduces human error. This automation is driven by the need for faster, more accurate sequencing results in research and clinical diagnostics. Another key driver is the rising prevalence of genetic disorders and cancer, which necessitates advanced sequencing technologies for early detection and personalized medicine. The market is also influenced by the growing investment in genomics research by governments and private entities. This investment is fostering innovation and expanding the application of NGS technologies. Additionally, the integration of artificial intelligence and machine learning in sequencing workflows is improving data analysis and interpretation. Opportunities abound in emerging markets where the adoption of NGS technologies is still in its nascent stages. Companies that offer cost-effective and scalable solutions are positioned to capitalize on this expanding market potential.

Restraints and Challenges:

The Automated NGS Library Preparation Market encounters significant restraints and challenges. Foremost, the high initial investment and operational costs deter smaller laboratories from adopting these technologies. The complexity of the equipment requires specialized training, which adds to the operational expenditure and limits rapid integration into existing workflows. Moreover, the regulatory landscape is evolving, with stringent guidelines that can delay product approvals and market entry. This creates uncertainty for companies and can slow innovation. Additionally, the market faces challenges with data management and analysis, as the volume of data generated by NGS technologies necessitates advanced bioinformatics tools and expertise. The lack of standardization across platforms also complicates the interoperability of systems, creating barriers for seamless integration. Lastly, there is a growing concern over data privacy and security, as sensitive genetic information must be protected against breaches, which adds another layer of complexity to market expansion.

Key Players:

PerkinElmer, Illumina, Qiagen, Takara Bio, Bio-Rad Laboratories, Agilent Technologies, Tecan Group, Hamilton Company, Beckman Coulter Life Sciences, Analytik Jena, Eppendorf, Zymo Research, Promega Corporation, New England Biolabs, Nimagen

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Deployment
  • 2.10 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Fully Automated
    • 4.1.2 Semi-Automated
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Reagents and Consumables
    • 4.2.3 Accessories
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Maintenance and Support
    • 4.3.2 Consultation
    • 4.3.3 Installation
    • 4.3.4 Training
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Bead-Based
    • 4.4.2 Microfluidics
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Software
    • 4.5.2 Hardware
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Diagnostics
    • 4.6.2 Drug Discovery
    • 4.6.3 Agricultural and Animal Research
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals and Clinics
    • 4.7.2 Pharmaceutical and Biotechnology Companies
    • 4.7.3 Academic and Research Institutes
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Sample Preparation
    • 4.8.2 Library Construction
    • 4.8.3 Sequencing
    • 4.8.4 Data Analysis
  • 4.9 Market Size & Forecast by Deployment (2020-2035)
    • 4.9.1 On-Premise
    • 4.9.2 Cloud-Based
  • 4.10 Market Size & Forecast by Functionality (2020-2035)
    • 4.10.1 High-Throughput
    • 4.10.2 Low-Throughput

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Process
      • 5.2.1.9 Deployment
      • 5.2.1.10 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Process
      • 5.2.2.9 Deployment
      • 5.2.2.10 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Process
      • 5.2.3.9 Deployment
      • 5.2.3.10 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Process
      • 5.3.1.9 Deployment
      • 5.3.1.10 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Process
      • 5.3.2.9 Deployment
      • 5.3.2.10 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Process
      • 5.3.3.9 Deployment
      • 5.3.3.10 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Process
      • 5.4.1.9 Deployment
      • 5.4.1.10 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Process
      • 5.4.2.9 Deployment
      • 5.4.2.10 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Process
      • 5.4.3.9 Deployment
      • 5.4.3.10 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Process
      • 5.4.4.9 Deployment
      • 5.4.4.10 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Process
      • 5.4.5.9 Deployment
      • 5.4.5.10 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Process
      • 5.4.6.9 Deployment
      • 5.4.6.10 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Process
      • 5.4.7.9 Deployment
      • 5.4.7.10 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Process
      • 5.5.1.9 Deployment
      • 5.5.1.10 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Process
      • 5.5.2.9 Deployment
      • 5.5.2.10 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Process
      • 5.5.3.9 Deployment
      • 5.5.3.10 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Process
      • 5.5.4.9 Deployment
      • 5.5.4.10 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Process
      • 5.5.5.9 Deployment
      • 5.5.5.10 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Process
      • 5.5.6.9 Deployment
      • 5.5.6.10 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Process
      • 5.6.1.9 Deployment
      • 5.6.1.10 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Process
      • 5.6.2.9 Deployment
      • 5.6.2.10 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Process
      • 5.6.3.9 Deployment
      • 5.6.3.10 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Process
      • 5.6.4.9 Deployment
      • 5.6.4.10 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Process
      • 5.6.5.9 Deployment
      • 5.6.5.10 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 PerkinElmer
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Illumina
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Qiagen
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Takara Bio
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Bio-Rad Laboratories
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Agilent Technologies
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Tecan Group
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Hamilton Company
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Beckman Coulter Life Sciences
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Analytik Jena
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Eppendorf
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Zymo Research
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Promega Corporation
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 New England Biolabs
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Nimagen
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us